Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and ...

17 August 2026 · By · Wire by Fusion42

Published

17 August 2026

Topic

operational-macro

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at biospace.com →

◆ Verified

Fusion42 · 17 August 2026 · Fusion42 review

Trinity Biotech secured an additional $7 million investment from Perceptive Advisors to support its strategic growth initiatives and has regained compliance with Nasdaq's minimum bid price requirement, enabling continued access to capital markets.

This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it between 14 Aug 2026 and 17 Aug 2026.

◆ ◆ The Wire takeaway

Your biotech company just cleared a key regulatory hurdle with Nasdaq compliance restored, unlocking access to capital markets. Use this opportunity to engage potential strategic partners while liquidity improves.

◆ Coverage

2 sources · first reported 14 Aug 2026 · latest 17 Aug 2026

◆ Related on Wire

◆ Topics

Biotechinvestmentnasdaq-compliancebiotech-growthstrategic-funding